TomoTherapy Incorporated

TomoTherapy Incorporated is a company based in Madison, Wisconsin, specializing in the development, marketing, and sale of advanced radiation therapy solutions. With a workforce of 91 employees, the company generates an annual revenue of $69.9 million. TomoTherapy offers a range of products designed to help treat various types of cancer. Their flagship platform, the TomoTherapy® system, integrates CT imaging with conformal radiation therapy to deliver precise and efficient treatments while minimizing harm to surrounding healthy tissue. This system includes the Hi·Art® treatment system, which has administered over three million CT-guided, helical intensity-modulated radiation therapy (IMRT) treatment fractions. They also offer the TomoHD™ system, designed for broader patient treatment capabilities, and the TomoMobile™ solution, which improves access to advanced cancer care. TomoTherapy's solutions are known for their speed, precision, and ability to reduce radiation exposure to healthy tissue. These features distinguish TomoTherapy's offerings in the field of radiation therapy. As of February 2011, over 350 TomoTherapy systems are in use across 24 countries worldwide. TomoTherapy Incorporated's stock trades on the NASDAQ Global Select Market under the symbol TOMO. For more information about the company and its products, visit TomoTherapy.com.